These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6223070)

  • 1. Selective failure of accessory cell function in Moloney murine leukemia virus-tolerant mice.
    Biasi G; Collavo D; Chieco-Bianchi L
    J Immunol; 1983 Jul; 131(1):16-8. PubMed ID: 6223070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
    Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
    Cerundolo V; Lahaye T; Horvath C; Zanovello P; Collavo D; Engers HD
    Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus-specific T cell response prevents lymphoma development in mice infected by intrathymic inoculation of Moloney leukaemia virus (M-MuLV).
    Zanovello P; Collavo D; Ronchese F; De Rossi A; Biasi G; Chieco-Bianchi L
    Immunology; 1984 Jan; 51(1):9-16. PubMed ID: 6228521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of accessory cells in the induction of a secondary cytotoxic response to Moloney murine sarcoma virus-induced tumors.
    Biasi G; Saggin L; Dazzi F; De Rossi A; Collavo D
    J Immunol; 1983 Mar; 130(3):1447-50. PubMed ID: 6185589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence and specificity of accessory cell impairment in M-MuLV neonatally injected mice.
    Biasi G; Saggin L; Dazzi F; Collavo D
    Transplant Proc; 1983 Dec; 15(4):2125-7. PubMed ID: 6608813
    [No Abstract]   [Full Text] [Related]  

  • 7. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
    Brawand P; Biasi G; Horvath C; Cerottini JC; MacDonald HR
    J Immunol; 1998 Feb; 160(4):1659-65. PubMed ID: 9469422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
    [No Abstract]   [Full Text] [Related]  

  • 9. The immune response to Moloney murine leukemia virus-induced tumors: induction of cytolytic T lymphocytes specific for both viral and tumor-associated antigens.
    Flyer DC; Burakoff SJ; Faller DV
    J Immunol; 1986 Dec; 137(12):3968-72. PubMed ID: 3491152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moloney murine leukemia virus tolerance in anti-CD4 monoclonal antibody-treated adult mice.
    Biasi G; Facchinetti A; Panozzo M; Zanovello P; Chieco-Bianchi L; Collavo D
    J Immunol; 1991 Oct; 147(7):2284-9. PubMed ID: 1833453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
    Flyer DC; Burakoff SJ; Faller DV
    J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
    Ng AK; Ames RS; McIntire RK; Herberman RB
    Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary and secondary in vitro generation of cytolytic T lymphocytes in the murine sarcoma virus system.
    Plata F; Cerottini JC; Brunner KT
    Eur J Immunol; 1975 Apr; 5(4):227-33. PubMed ID: 185057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response to Moloney murine leukemia virus nonviral, tumor-associated antigens fails to provide in vivo tumor protection.
    Jiang D; Flyer DC
    J Immunol; 1992 Feb; 148(3):974-80. PubMed ID: 1730885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-H-2 histocompatibility antigens encoded by Moloney-murine leukemia virus in Mov mouse strains are detectable by skin grafting and cytolytic T lymphocytes.
    Wettstein PJ; Colombo MP; Jaenisch R
    J Immunol; 1988 Jun; 140(12):4337-41. PubMed ID: 3286772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressor T cells regulate the cytolytic T lymphocyte response to syngeneic tumors induced by murine sarcoma virus (MSV) in the mouse.
    Plata F; MacDonald HR; Shain B
    J Immunol; 1979 Aug; 123(2):852-60. PubMed ID: 156765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a viral antigen recognized by H-2-restricted cytolytic T lymphocytes on a murine leukemia virus-induced tumor.
    Plata F; Kalil J; Zilber MT; Fellous M; Lévy D
    J Immunol; 1983 Nov; 131(5):2551-6. PubMed ID: 6605389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors.
    Schmid DS; Rouse BT
    J Immunol; 1983 Jul; 131(1):479-84. PubMed ID: 6223080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary in vitro generation of cytolytic T-lymphocytes (CTL's) in the murine sarcoma virus system. Virus-specific CTL induction across the H-2 barrier.
    Collavo D; Parenti A; Biasi G; Chieco-Bianchi L; Colombatti A
    J Natl Cancer Inst; 1978 Sep; 61(3):885-90. PubMed ID: 80457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.